J.L. Morison Son & Jones (Ceylon) PLC operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares J.L. Morison Son & Jones (Ceylon) PLC with three other
pharmaceutical manufacturers in Asia:
Syncom Formulations (India) Limited
sales of 1.59 billion Indian Rupees [US$22.38 million]
Kwality Pharmaceuticals Ltd
(1.37 billion Indian Rupees [US$19.40 million]
Jagsonpal Pharmaceuticals Limited
based in India
(1.27 billion Indian Rupees [US$17.85 million]
J.L. Morison Son & Jones (Ceylon) PLC reported sales of 3.80 billion Sri Lanka Rupees (US$21.28 million)
March of 2018.
decrease of 5.4%
versus 2017, when the company's sales were 4.02 billion Sri Lanka Rupees.
Contributing to the drop in overall sales was the 3.9% decline
in Mnaufacturing and Trading/consumer, from 1.22 billion Sri Lanka Rupees to 1.18 billion Sri Lanka Rupees.
There were also decreases in sales in
Pharmaceuticals (down 0.9% to 2.62 billion Sri Lanka Rupees)